JPS54148090A - Peroral cholesterol-depressant - Google Patents

Peroral cholesterol-depressant

Info

Publication number
JPS54148090A
JPS54148090A JP5597978A JP5597978A JPS54148090A JP S54148090 A JPS54148090 A JP S54148090A JP 5597978 A JP5597978 A JP 5597978A JP 5597978 A JP5597978 A JP 5597978A JP S54148090 A JPS54148090 A JP S54148090A
Authority
JP
Japan
Prior art keywords
cholesterol
peroral
depressant
chitin
chitosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5597978A
Other languages
Japanese (ja)
Inventor
Takaaki Kobayashi
Tatsuro Fujikawa
Michihiro Sugano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP5597978A priority Critical patent/JPS54148090A/en
Publication of JPS54148090A publication Critical patent/JPS54148090A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

PURPOSE: To prepare a new peroral cholesterol-depressant containing chitosan.
CONSTITUTION: Chitosan, which is a basic polysaccharide having free amino groups, is prepared by N-deacetylation of chitin, e.g. by treating chitin with a highly concentrated alkali solution.
EFFECT: Tasteless and odorless; easy to take. LD50 is 3g/kg; high safety.
USE: The cholesterol level in blood is depressed. The medicine is taken alone or together with foods: Dose, 1W30 g/day.
COPYRIGHT: (C)1979,JPO&Japio
JP5597978A 1978-05-11 1978-05-11 Peroral cholesterol-depressant Pending JPS54148090A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5597978A JPS54148090A (en) 1978-05-11 1978-05-11 Peroral cholesterol-depressant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5597978A JPS54148090A (en) 1978-05-11 1978-05-11 Peroral cholesterol-depressant

Publications (1)

Publication Number Publication Date
JPS54148090A true JPS54148090A (en) 1979-11-19

Family

ID=13014185

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5597978A Pending JPS54148090A (en) 1978-05-11 1978-05-11 Peroral cholesterol-depressant

Country Status (1)

Country Link
JP (1) JPS54148090A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0105106A2 (en) * 1982-08-30 1984-04-11 Daito Koeki Kabushiki Kaisha Anti-bacterial composition
JP2002521338A (en) * 1998-07-21 2002-07-16 アルペンストック・ホールディングス・リミテッド Antilipidemic preparation
JP2009519251A (en) * 2005-12-16 2009-05-14 ディーエヌピー・カナダ・インコーポレーテッド Chitin derivatives for hyperlipidemia
JP2009531306A (en) * 2006-03-03 2009-09-03 コルネッリ・ウムベルト A composition comprising chitosan in the form of a drug or supplement suitable for comprehensive therapeutic treatment or comprehensive prevention of metabolic syndrome
US8722127B2 (en) 2005-02-03 2014-05-13 Cor. Con. International S.R.L. Bakery and pasta products comprising acidified chitosan

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0105106A2 (en) * 1982-08-30 1984-04-11 Daito Koeki Kabushiki Kaisha Anti-bacterial composition
JP2002521338A (en) * 1998-07-21 2002-07-16 アルペンストック・ホールディングス・リミテッド Antilipidemic preparation
US8722127B2 (en) 2005-02-03 2014-05-13 Cor. Con. International S.R.L. Bakery and pasta products comprising acidified chitosan
JP2009519251A (en) * 2005-12-16 2009-05-14 ディーエヌピー・カナダ・インコーポレーテッド Chitin derivatives for hyperlipidemia
JP2009531306A (en) * 2006-03-03 2009-09-03 コルネッリ・ウムベルト A composition comprising chitosan in the form of a drug or supplement suitable for comprehensive therapeutic treatment or comprehensive prevention of metabolic syndrome
US9050356B2 (en) 2006-03-03 2015-06-09 Cor. Con. International S.R.L. Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome

Similar Documents

Publication Publication Date Title
ES8201596A1 (en) their preparation and use as medicines.
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
SE9401406D0 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
IE45753L (en) Combating virus infections
CZ149095A3 (en) Liquid aerosol preparation containing a medicament and stabilization process of said preparation
EP0293826A3 (en) Therapeutic and prophylactic application of sulfated polysaccharides against aids
JPS5356251A (en) Prevention of devitrifiction of aromatic polyester
NO157843C (en) PROCEDURE FOR PREPARING A DISSOLVED INSULIN PREPARATION.
NO951240D0 (en) Use of IL-10 to prevent or treat insulin-dependent diabetes mellitus
JPS54148090A (en) Peroral cholesterol-depressant
JPS6434909A (en) Cosmetic
SE7906467L (en) HYPO-BETA-LIPOPROTEINEMIC DIETIC, PROCEDURES FOR PREPARING IT AND USING IT
JPS52130922A (en) Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient
DE3481057D1 (en) 2-SULFAMOYLBENZO (B) THIOPHENE DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF INCREASED EYE PRESSURE.
GB1375572A (en)
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
JPS57112331A (en) Medical composition of ganoderma lucidum component
KR910015697A (en) Rejuvenation method using herbal medicine as raw material
HUT59011A (en) Process for producing composition, and its active ingredient, suitable for inactivating or removing harmful compounds in blood and other extracellular liquids
JPS55113721A (en) Immunity regulator
JPS5427456A (en) Liquid crystal orientation treatment method
JPS5437888A (en) Preparation of pullulan
JPS52152487A (en) Preparation of polyisoprene
JPS5417182A (en) Preparation of choline-oxidase
JPS5354859A (en) Method of treating waste liquid containing resin composed of sodium alginate